Emergency Contraception Clinical Trial
Official title:
A Prospective Trial of the Copper T380 IUD or Oral Levonorgestrel and the Levonorgestrel IUD Initiated With Emergency Contraception
The purpose of this study is to see how often women who come to a family planning clinic for emergency contraception, the morning after pill, are willing to use either the copper IUD or the levonorgestrel IUD. The investigators will also see if pregnancies occur in those choosing the levonorgestrel IUD and if people continue to use the IUD for 1 year.
Widely available oral levonorgestrel (LNG) for emergency contraception (EC) has not reduced
unplanned pregnancy rates. However, our study of the copper T380 IUD vs. oral LNG for EC
showed lower pregnancy rates 12 months after presenting for EC in the copper IUD group.
Because there is a strong preference for the LNG IUD among women offered the IUD, the
objective of this research project is to initiate investigation into, and use of the LNG IUD
in the setting of EC. Our experienced team of EC researchers proposes the following aims to
provide needed information in this understudied area:
Aim 1: To assess uptake of the LNG IUD vs. the copper IUD among women presenting for EC
exposed to standardized counseling.
Aim 2: Gather baseline data on one-year continuation and pregnancy rates from women
initiating the LNG IUD vs. the copper T380 IUD when presenting for EC.
Aim 3: Assess willingness of women presenting for EC to participate in a future randomized
controlled trial comparing the LNG IUD vs. the copper T380 IUD for EC.
The study aims will be accomplished with a prospective observational trial of women who
choose either method of EC. The investigative team will recruit 180 women who present for EC
at two participating family planning clinics and follow study participants for 12 months.
This project will compare continuation and pregnancy rates between LNG and copper IUD users
in the year following presentation for EC. This proposal is another aspect in our growing
research program offering highly effective contraception at the time of EC presentation.
Results of this project will direct future study in this area aimed at reducing population
unplanned pregnancy rates among EC users with the potential to inform a future RCT of the
LNG vs. copper IUD for EC.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00271583 -
Efficacy Trial of CDB 2914 for Emergency Contraception
|
Phase 2/Phase 3 | |
Completed |
NCT00777556 -
Emergency Contraception Actual Use Study
|
Phase 3 | |
Completed |
NCT00677755 -
Medical Abortion for Emergency Contraception Failure
|
N/A | |
Recruiting |
NCT06162611 -
Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
|
Phase 4 | |
Completed |
NCT00411684 -
Safety and Efficacy of CDB-2914 for Emergency Contraception
|
Phase 3 | |
Completed |
NCT01569737 -
Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
|
||
Completed |
NCT03208985 -
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
|
Phase 3 | |
Completed |
NCT02078414 -
Continued Use of Effective Contraception After Use of Emergency Contraception
|
||
Completed |
NCT01569113 -
Assessment of Effects on Ovarian Activity of a Combined Oral Contraceptive Pill When Preceded by the Intake of ellaOne® or Placebo.
|
Phase 4 | |
Recruiting |
NCT03120728 -
Application for the Etonogestrel/Ethinyl Estradiol Ring
|
Phase 4 | |
Active, not recruiting |
NCT02076217 -
Quick Start of Highly Effective Contraception
|
||
Not yet recruiting |
NCT04172584 -
Awareness & Use of Emergency Contraception
|
||
Completed |
NCT03395756 -
Depot Medroxyprogesterone Acetate as Emergency Contraception
|
Early Phase 1 | |
Completed |
NCT03614494 -
Piroxicam and Levonorgestrel Co-treatment for Emergency Contraception
|
Phase 2/Phase 3 |